Serious problems with antimalarial drugs.
D000962:Antimalarials / Q000009:adverse effects* / Q000494:pharmacology; D002738:Chloroquine / Q000009:adverse effects; D003622:Dapsone / Q000009:adverse effects; D004338:Drug Combinations / Q000009:adverse effects; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D010963:Plasmodium falciparum / Q000187:drug effects; D010966:Plasmodium vivax / Q000187:drug effects; D011739:Pyrimethamine / Q000009:adverse effects; D011803:Quinine / Q000009:adverse effects; D013413:Sulfadoxine / Q000009:adverse effects
D000962:Antimalarials; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; C001678:Maloprim; D013413:Sulfadoxine; D002738:Chloroquine; D003622:Dapsone; D011803:Quinine; D011739:Pyrimethamine